Atia Vision

About:

Atia Medical focuses on advancing eye care through the innovation of ophthalmic devices, diagnostics, and pharmaceuticals.

Website: http://atiavision.com/

Top Investors: Cormorant Asset Management, AMED Ventures, Rising Tide, Shangbay Capital, The Capital Partnership

Description:

Atia Medical is a medical device company focusing on advancing eye care through the innovation of ophthalmic devices, diagnostics, and pharmaceuticals. The company is focused on developing advanced solutions that get to market faster, reduce risk, increase impact, and forge a path toward a world where all people are able to lead longer healthier lives. They improving patient outcomes through the development of a modular presbyopia-correcting accommodating intraocular lens. Atia Vision modular intraocular lens technology features an accommodating base responsive to the ciliary muscles, simulating the natural mechanism of the eye and fixed lens element that allows for subsequent refractive correction. The company's unique technology enables natural accommodation, utilizing the ciliary muscles of the eye and providing for subsequent refractive correction, to restore the full range of functional vision for cataract patients. Atria Vision was founded in 2012 and is headquartered in Campbell, California, United States.

Total Funding Amount:

$111M

Headquarters Location:

Campbell, California, United States

Founded Date:

2012-01-01

Contact Email:

info(AT)atiavision.com

Founders:

Claudio Argento

Number of Employees:

11-50

Last Funding Date:

2022-08-22

IPO Status:

Private

Industries:

© 2025 bioDAO.ai